Citations

Citations to this article as recorded by  

• Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition
  Filiz Akyüz, Yoon Kyo An, Jakob Begun, Satimai Aniwan, Huu Hoang Bui, Webber Chan, Chang Hwan Choi, Nazeer Chopdat, Susan J Connor, Devendra Desai, Emma Flanagan, Taku Kobayashi, Allen Yu-Hung Lai, Rupert W Leong, Alex Hwong-Ruey Leow, Wai Keung Leung, Ju
  Intestinal Research.2025; 23(1): 37.     CrossRef
• Understanding Medication Nonadherence in Crohn’s Disease Patients: A Qualitative Evaluation
  Robert E Brady, Jessica K Salwen-Deremer, Natalie C Tunnell, Michael W Winter
  Inflammatory Bowel Diseases.2024; 30(11): 2046.     CrossRef
• Attitudes to medication and effects of IBD nursing service among patients with inflammatory bowel disease in Taiwan
  Chen‐Ta Yang, Tsui‐Chun Hsu, Yang‐Yuan Chen, Siou‐Ping Huang, Hsu‐Heng Yen
  Advances in Digestive Medicine.2024; 11(3): 162.     CrossRef
• COMPLIANCE AND QUALITY OF LIFE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
  R.J. JAMOLOVA, D.K. MUKHABBATOV, D.T. RAKHMONOV, S.G. ALI-ZADE
  AVICENNA BULLETIN.2024; 26(1): 76.     CrossRef
• High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease
  Esma H. San, Angelique Egberts, Caroline W. Th. van Dijck - van Boetzelaer, Rachel L. West, Erwin C. Vasbinder
  European Journal of Clinical Pharmacology.2024; 80(7): 1089.     CrossRef
• MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations
  Ferdinando D'Amico, Francesca Lusetti, Laurent Peyrin-Biroulet, Silvio Danese
  Digestive and Liver Disease.2024; 56(9): 1425.     CrossRef
• Motivational Interviewing as a Strategy to Improve Adherence in IBD Treatment: An Integrative Review Amidst COVID-19 Disruptions
  Caterina Mercuri, Maria Catone, Vincenzo Bosco, Assunta Guillari, Teresa Rea, Patrizia Doldo, Silvio Simeone
  Healthcare.2024; 12(12): 1210.     CrossRef
• The economic impact of suboptimal treatment and treatment switch among patients with Crohn’s disease treated with a first-line biologic – A US retrospective claims database study
  Patrick Gagnon-Sanschagrin, Myrlene Sanon, Mikhaïl Davidson, Cynthia Willey, Sumesh Kachroo, Timothy Hoops, Dominik Naessens, Annie Guerin, Martin Cloutier
  Journal of Medical Economics.2024; 27(1): 931.     CrossRef
• A Practical Approach to Identify Non-Adherence to Mesalamine Therapy in Inflammatory Bowel Disease
  Filippo Vernia, Giorgia Burrelli Scotti, Raffaele Borghini, Mario Muselli, Stefano Necozione, Giovanni Moretta, Lorenza Scurti, Giuseppe Donato
  Gastroenterology Insights.2024; 15(3): 754.     CrossRef
• Use of Complementary and Alternative Therapies in People with Inflammatory Bowel Disease
  Laura Frank, Kelly Lambert
  International Journal of Environmental Research and Public Health.2024; 21(9): 1140.     CrossRef
• Obstacles to Medication Adherence for Patients with Inflammatory Bowel Disease: A Qualitative Study in East China
  Fen Xu, Jingjing Xing, Mingna Fan, Zhiping Zhu, Yan Chen, Wen Hu, Yunxian Zhou
  Patient Preference and Adherence.2024; Volume 18: 2481.     CrossRef
• A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
  Yanfang Liu, Choo Hua Goh, Hong Qiu, Kuan-Chih Huang, Hsingwen Chung, Carine Saadoun
  Annals of Pharmacotherapy.2023; 57(9): 1053.     CrossRef
• Development and implementation of a laboratory monitoring dashboard to reduce treatment gaps in inflammatory bowel disease
  Miranda Kozlicki, Bridget Lynch, Tony Donoho, Patrick Nichols, Autumn D Zuckerman
  American Journal of Health-System Pharmacy.2023; 80(Supplement): S55.     CrossRef
• Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease
  Edward V. Loftus, Jenny Griffith, Ezequiel Neimark, Alexandra Song, Kori Wallace, Sujani Nannapaneni, Ji Zhou, Rachel Byrne, Kristina Kligys, Yinuo Pang, Xiaomei Liao, Jasmina Kalabic, Marla Dubinsky
  Advances in Therapy.2023; 40(5): 2311.     CrossRef
• Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel Disease
  Ashkan Rezazadeh Ardabili, Dirk van Esser, Dion Wintjens, Mia Cilissen, Debbie Deben, Zlatan Mujagic, Fritzi Russ, Laurents Stassen, Adriaan A Van Bodegraven, Dennis Wong, Bjorn Winkens, Daisy Jonkers, Mariëlle Romberg-Camps, Marie J Pierik
  Journal of Crohn's and Colitis.2023; 17(7): 1079.     CrossRef
• Factors contributing to flares of ulcerative colitis in North India- a case-control study
  Vishavdeep Singh Rana, Gaurav Mahajan, Amol N. Patil, Anupam K. Singh, Vaneet Jearth, Aravind Sekar, Harjeet Singh, Atul Saroch, Usha Dutta, Vishal Sharma
  BMC Gastroenterology.2023;[Epub]     CrossRef
• An education‐based telehealth group improves the management and clinical outcomes of patients with inflammatory bowel disease in China (THEIM study)
  Jian Kang, Juan Su, Jing Wang, Haixia Ren, Anning Yin, Jiao Li, Qian Zhou, Yang Wang, Peng Zhu, Liping Zou, Wei Wang, Zhishun Tang, Weiguo Dong, Yijuan Ding, Ping An
  United European Gastroenterology Journal.2023; 11(10): 960.     CrossRef
• Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening
  Zohar Ben-Shatach, Tomer Ziv-Baran, Ella Fudim, Miri Yavzori, Orit Picard, Asaf Levartovsky, Limor Selinger, Batia Weiss, Uri Kopylov, Rami Eliakim, Bella Ungar
  Therapeutic Advances in Gastroenterology.2022;[Epub]     CrossRef
• Medication Adherence and Its Influencing Factors Among Inflammatory Bowel Disease Patients in China
  Fen Xu, Juping Tang, Zhiping Zhu, Yan Chen, Wen Hu, Sha Lu, Yunxian Zhou, Ding Lin
  International Journal of General Medicine.2022; Volume 15: 4141.     CrossRef
• Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents
  Dominic Pilon, Zhijie Ding, Erik Muser, Ameur M Manceur, Maude Vermette-Laforme, Marie-Hélène Lafeuille, Patrick Lefebvre
  Crohn's & Colitis 360.2022;[Epub]     CrossRef
• Medication adherence in women with IBD of childbearing age likely associated with disease knowledge
  Robyn Laube, Christian Selinger, Rupert W. Leong
  Therapeutic Advances in Gastroenterology.2022;[Epub]     CrossRef
• Utility of the MARS-5 in Assessing Medication Adherence in IBD
  James K Stone, Leigh Anne Shafer, Lesley A Graff, Lisa Lix, Kelcie Witges, Laura E Targownik, Clove Haviva, Kathryn Sexton, Charles N Bernstein
  Inflammatory Bowel Diseases.2021; 27(3): 317.     CrossRef
• Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes
  Chikako Watanabe, Masakazu Nagahori, Toshimitsu Fujii, Kaoru Yokoyama, Naoki Yoshimura, Taku Kobayashi, Hirokazu Yamagami, Kazuya Kitamura, Kagaya Takashi, Shiro Nakamura, Makoto Naganuma, Shunji Ishihara, Motohiro Esaki, Maria Yonezawa, Reiko Kunisaki, A
  Digestive Diseases and Sciences.2021; 66(2): 577.     CrossRef
• Selected psychological predictors of medication adherence in the older adults with chronic diseases
  Magdalena Gruszczyńska, Julia Wyszomirska, Anna Daniel‐Sielańczyk, Monika Bąk‐Sosnowska
  Nursing Open.2021; 8(1): 317.     CrossRef
• Impacto de la pandemia covid-19 en la adherencia al tratamiento en pacientes con enfermedad inflamatoria intestinal: experiencia de un centro terciario en Chile
  Rodrigo Quera, Daniela Simian, Lilian Flores, Patricio Ibáñez, Carolina Figueroa
  Gastroenterología y Hepatología.2021; 44(9): 654.     CrossRef
• Adherence to Subcutaneous Biological Therapies in Patients with Inflammatory Rheumatic Diseases and Inflammatory Bowel Disease: A Systematic Review
  Juan C Nieto, Claudia Arajol, Loreto Carmona, Carlos Marras, Luis Cea-Calvo
  Immunotherapy.2021; 13(5): 433.     CrossRef
• Researching Interventions to Improve Medication Adherence in Ulcerative Colitis Patients
  Mila Palma Pacheco, Flora Maria Lorenzo Fortes, Raquel Rocha dos Santos, Genoile Oliveira Santana Silva
  Journal of Coloproctology.2021; 41(01): 096.     CrossRef
• Persistence as a Robust Indicator of Medication Adherence-Related Quality and Performance
  Enrica Menditto, Caitriona Cahir, Sara Malo, Isabel Aguilar-Palacio, Marta Almada, Elisio Costa, Anna Giardini, María Gil Peinado, Mireia Massot Mesquida, Sara Mucherino, Valentina Orlando, Carlos Luis Parra-Calderón, Enrique Pepiol Salom, Przemyslaw Kard
  International Journal of Environmental Research and Public Health.2021; 18(9): 4872.     CrossRef
• Effect of point‐of‐care gastrointestinal ultrasound on decision‐making and management in inflammatory bowel disease
  Antony B. Friedman, Anil Asthana, Simon R. Knowles, Aphra Robbins, Peter R. Gibson
  Alimentary Pharmacology & Therapeutics.2021; 54(5): 652.     CrossRef
• Impact of the COVID-19 pandemic on treatment adherence in patients with inflammatory bowel disease: Experience of a tertiary hospital in Chile
  Rodrigo Quera, Daniela Simian, Lilian Flores, Patricio Ibáñez, Carolina Figueroa
  Gastroenterología y Hepatología (English Edition).2021; 44(9): 654.     CrossRef
• Adherence to treatment in patients with inflammatory bowel disease
  K. A. Andreev, A. V. Gorbenko, Yu. P. Skirdenko, N. A. Nikolaev, M. A. Livzan, G. R. Bikbavova, M. M. Fedorin
  Bulletin of Siberian Medicine.2021; 20(3): 120.     CrossRef
• Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study
  Juan Lasa, Gustavo Correa, Claudia Fuxman, Laura Garbi, Maria Eugenia Linares, Pablo Lubrano, Astrid Rausch, Martin Toro, Martin Yantorno, Ignacio Zubiaurre, Laurent Peyrin-Biroulet, Pablo Olivera
  Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
• Knowledge of disease and self‐management of adolescents with inflammatory bowel diseases
  Alex Krauthammer, Tal Harel, Noam Zevit, Dror S. Shouval, Raanan Shamir, Batia Weiss
  Acta Paediatrica.2020; 109(10): 2119.     CrossRef
• The burden of cost in inflammatory bowel disease: a medical economic perspective
  Jonathan A. Beard, Benjamin H. Click
  Current Opinion in Gastroenterology.2020; 36(4): 310.     CrossRef
• İnflamatuar Bağırsak Hastalıkları Olan Bireylerde İlaç Uyumu ve Yaşam Kalitesi
  Nazli ÖZTÜRK, Yasemin YILDIRIM
  Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi.2020; 2(3): 192.     CrossRef
• Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus
  Marco Daperno, Alessandro Armuzzi, Silvio Danese, Walter Fries, Giuseppina Liguori, Ambrogio Orlando, Claudio Papi, Mariabeatrice Principi, Fernando Rizzello, Angelo Viscido, Paolo Gionchetti
  Gastroenterology Research and Practice.2019; 2019: 1.     CrossRef
• The Development of a Screening Tool to Identify and Classify Nonadherence in Inflammatory Bowel Disease
  Aria Zand, Audrey Nguyen, Zack Stokes, Welmoed van Deen, Courtney Reynolds, Magdalena Dimitrova, Ariela Khandadash, Miriam Dvorsky, Jenny Sauk, Eric Esrailian, Daniel Hommes
  Crohn's & Colitis 360.2019;[Epub]     CrossRef
• Adherence to therapy of patients with inflammatory bowel diseases
  A I Parfenov, A V Kagramanova, A F Babayan, O V Knyazev
  Terapevticheskii arkhiv.2018; 90(12): 4.     CrossRef